EE278 Model-Projected Long-Term Clinical Outcomes of Exagamglogene Autotemcel (exa-cel) Gene-Edited Therapy in Patients with Sickle Cell Disease with Recurrent Vaso-Occlusive Crises in the United Kingdom
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.544
https://www.valueinhealthjournal.com/article/S1098-3015(23)03674-4/fulltext
Title :
EE278 Model-Projected Long-Term Clinical Outcomes of Exagamglogene Autotemcel (exa-cel) Gene-Edited Therapy in Patients with Sickle Cell Disease with Recurrent Vaso-Occlusive Crises in the United Kingdom
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)03674-4&doi=10.1016/j.jval.2023.09.544
First page :
Section Title :
Open access? :
No
Section Order :
10035